Beta Bionics Inc
BBNX23.050USD
-0.060-0.26%
收盘 09/18, 16:00（美东）报价延迟15分钟
1.00B总市值
亏损市盈率 TTM
关于 Beta Bionics Inc 公司
Beta Bionics, Inc. 是一家商业阶段的医疗器械公司，致力于设计、开发和商业化各种解决方案，以改善需要胰岛素的糖尿病患者 (PWD) 的健康。该公司的产品 iLet Bionic Pancreas (iLet) 是一种胰岛素输送装置，经美国食品药品管理局 (FDA) 批准，利用自适应闭环算法自主确定每次胰岛素剂量，而无需用户计算碳水化合物摄入量。iLet 用于治疗 1 型糖尿病 (T1D)。该公司的解决方案包括成人版 iLet、儿童版 iLet、Bionic Circle App 和 iLet Simulator。该公司正处于开发胰岛素泵的早期阶段，该泵旨在直接粘附在皮肤上并无需导管即可给药，在糖尿病行业中通常称为贴片泵。它还处于开发 iLet 双激素配置的早期阶段。
公司简介
公司代码BBNX
公司名称Beta Bionics Inc
上市日期Jan 30, 2025
CEOMr. Sean Saint
员工数量291
证券类型Ordinary Share
年结日Jan 30
公司地址11 Hughes
城市IRVINE
上市交易所NASDAQ Global Market Consolidated
国家United States of America
邮编92618
电话19494277785
网址https://www.betabionics.com
公司代码BBNX
上市日期Jan 30, 2025
CEOMr. Sean Saint
公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Steven Russell, M.D., Ph.D.
Dr. Steven Russell, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
71.02K
-1.41%
Ms. Christy Jones
Ms. Christy Jones
Independent Director
Independent Director
59.44K
--
Mr. Gerard J. Michel
Mr. Gerard J. Michel
Independent Director
Independent Director
12.55K
--
Mr. Adam Lezack
Mr. Adam Lezack
Independent Chairman of the Board
Independent Chairman of the Board
11.25K
--
Dr. Maria Palasis, Ph.D.
Dr. Maria Palasis, Ph.D.
Independent Director
Independent Director
11.25K
--
Mr. Sean D. Carney
Mr. Sean D. Carney
Independent Director
Independent Director
11.25K
--
Mr. Blake Beber
Mr. Blake Beber
Investor Relations
Investor Relations
--
--
Mr. Sean Saint
Mr. Sean Saint
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
-100.00%
Mr. Dan Dearen
Mr. Dan Dearen
Independent Director
Independent Director
--
--
Mr. Stephen Feider
Mr. Stephen Feider
Chief Financial Officer
Chief Financial Officer
--
-100.00%
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Steven Russell, M.D., Ph.D.
Dr. Steven Russell, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
71.02K
-1.41%
Ms. Christy Jones
Ms. Christy Jones
Independent Director
Independent Director
59.44K
--
Mr. Gerard J. Michel
Mr. Gerard J. Michel
Independent Director
Independent Director
12.55K
--
Mr. Adam Lezack
Mr. Adam Lezack
Independent Chairman of the Board
Independent Chairman of the Board
11.25K
--
Dr. Maria Palasis, Ph.D.
Dr. Maria Palasis, Ph.D.
Independent Director
Independent Director
11.25K
--
Mr. Sean D. Carney
Mr. Sean D. Carney
Independent Director
Independent Director
11.25K
--
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2024
FY2023
业务USD
名称
营收
占比
DME channel - iLet
46.62M
71.58%
DME channel - Single-use products
12.19M
18.72%
PBP channel - Single-use products
4.22M
6.48%
PBP channel - iLet
2.10M
3.22%
暂无数据
业务
地区
业务USD
名称
营收
占比
DME channel - iLet
46.62M
71.58%
DME channel - Single-use products
12.19M
18.72%
PBP channel - Single-use products
4.22M
6.48%
PBP channel - iLet
2.10M
3.22%
股东统计
更新时间: 9月3日 周三
更新时间: 9月3日 周三
持股股东
股东类型
持股股东
持股股东
占比
Eventide Asset Management, LLC
11.35%
Farallon Capital Management, L.L.C.
9.67%
Wellington Management Company, LLP
8.98%
Soleus Capital Management, L.P.
8.79%
Sands Capital Ventures LLC
8.21%
其他
53.01%
持股股东
持股股东
占比
Eventide Asset Management, LLC
11.35%
Farallon Capital Management, L.L.C.
9.67%
Wellington Management Company, LLP
8.98%
Soleus Capital Management, L.P.
8.79%
Sands Capital Ventures LLC
8.21%
其他
53.01%
股东类型
持股股东
占比
Hedge Fund
37.10%
Investment Advisor/Hedge Fund
31.62%
Investment Advisor
23.34%
Research Firm
7.39%
Private Equity
3.67%
Venture Capital
1.19%
Individual Investor
0.64%
Sovereign Wealth Fund
0.35%
Pension Fund
0.21%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
161
44.89M
103.27%
+24.04M
2025Q1
149
45.45M
104.86%
+26.05M
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Eventide Asset Management, LLC
4.93M
11.37%
+70.98K
+1.46%
Mar 31, 2025
Farallon Capital Management, L.L.C.
3.33M
7.69%
+55.00K
+1.68%
Mar 31, 2025
Wellington Management Company, LLP
3.90M
9%
+3.90M
--
Mar 31, 2025
Soleus Capital Management, L.P.
3.40M
7.83%
+1.10M
+47.92%
Mar 31, 2025
Sands Capital Ventures LLC
3.15M
7.28%
+50.63K
+1.63%
Apr 02, 2025
RTW Investments L.P.
3.30M
7.61%
+200.68K
+6.48%
Mar 31, 2025
Morgan Stanley & Co. LLC
1.39M
3.22%
+1.39M
--
Mar 31, 2025
Omega Fund Management, LLC
1.99M
4.59%
+294.37K
+17.38%
Mar 31, 2025
Perceptive Advisors LLC
2.20M
5.08%
+2.20M
--
Mar 31, 2025
Deerfield Management Company, L.P.
1.02M
2.34%
+1.02M
--
Mar 31, 2025
查看更多
持股ETF
更新时间: 9月2日 周二
更新时间: 9月2日 周二
机构名称
占比
Goldman Sachs Innovate Equity ETF
0.06%
Proshares Ultra Russell 2000
0.01%
iShares Russell 2000 Growth ETF
0.01%
Schwab U.S. Small-Cap ETF
0.01%
ProShares Hedge Replication ETF
0.01%
Global X Russell 2000 ETF
0.01%
ProShares UltraPro Russell2000
0.01%
iShares Russell 2000 ETF
0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
0.01%
Schwab U.S. Broad Market ETF
0%
查看更多
Goldman Sachs Innovate Equity ETF
占比0.06%
Proshares Ultra Russell 2000
占比0.01%
iShares Russell 2000 Growth ETF
占比0.01%
Schwab U.S. Small-Cap ETF
占比0.01%
ProShares Hedge Replication ETF
占比0.01%
Global X Russell 2000 ETF
占比0.01%
ProShares UltraPro Russell2000
占比0.01%
iShares Russell 2000 ETF
占比0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
占比0.01%
Schwab U.S. Broad Market ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
